Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€19.30
14.06.21
€22.00
14.06.22
6.74%
17.06.21

Could be worthwhile Investment >10% per year
buy
CareCloud Inc.

Start price
Target price
Perf. (%)
€7.30
12.06.21
€8.50
12.06.22
-6.16%
10.07.21

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
CareCloud Inc.

Start price
Target price
Perf. (%)
€7.30
12.06.21
-
12.06.22
-55.62%
12.06.22

buy
Novan Inc

Start price
Target price
Perf. (%)
€12.12
12.06.21
-
12.06.22
-81.58%
13.06.22

Could be worthwhile Investment >10% per year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€18.77
11.06.21
€23.20
11.06.22
-14.32%
24.06.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.35
31.05.21
-
31.05.24
40.10%
11.03.24

Could be worthwhile Investment >10% per year
buy
Haemato AG

Start price
Target price
Perf. (%)
€29.20
31.05.21
-
31.05.24
-36.99%
11.03.24

Could be worthwhile Investment >10% per year
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.74
31.05.21
€15.00
31.05.22
-60.61%
01.06.22

Fair valuation
Strong uniques
Leading role in innovation
Bad rating
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.18
31.05.21
€4.00
31.05.22
4.59%
14.06.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.44
31.05.21
€4.00
31.05.22
-2.46%
07.06.21

Could be worthwhile Investment >10% per year
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€4.16
31.05.21
€7.00
31.05.22
1.44%
14.06.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.24
31.05.21
€12.00
31.05.22
0.62%
14.06.21

Could be very worthwhile Investment >20% year
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€2.86
29.05.21
-
29.05.22
-71.59%
30.05.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€125.18
28.05.21
€200.00
28.05.22
-35.69%
29.01.22

Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€9.52
27.05.21
€32.00
27.05.22
-55.61%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€75.60
26.05.21
€82.00
26.05.22
-36.11%
27.05.22

buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€3.92
17.05.21
€5.00
17.05.22
6.12%
31.05.21

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.65
17.05.21
€8.00
17.05.22
1.50%
31.05.21

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.44
17.05.21
€6.00
17.05.22
2.70%
31.05.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€6.73
17.05.21
€8.00
17.05.22
7.58%
31.05.21

Could be very worthwhile Investment >20% year
buy
Calithera Biosciences Inc.

Start price
Target price
Perf. (%)
€35.80
17.05.21
-
17.05.22
-88.46%
18.05.22

Could be worthwhile Investment >10% per year
buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€26.00
16.05.21
€40.00
16.05.22
-5.77%
29.01.22

Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management